Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008


Oral Ivermectin in Complicated Scabies on Hospitalized Patients at the National Institute of Child Health

Juan Pastor Medina Flores and Carlos Gonzales Saravia

In this series of cases it can be shown that the age group with the greatest number of complications was those from 1 month to 24 months. Impetiginization was the most frequent type of complication, oxacillin was the most used antibiotic and systemic corticoid was indicated in 30% of the cases.

Oral ivermectin, the only drug for systemic use, was indicated alone or in combination in 73% of the cases. From these cases, 57% were between 1 to 12 months old, without evidence of side effects. It could be considered as a first line treatment for impetiginized scabies in this group age

Published Date: 2019-01-17; Received Date: 2018-11-28